skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
ABVE Regimen (Code C67162)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: ABVE Regimen

Definition: A regimen containing doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate and etoposide used in combination with radiation therapy for the treatment of low-risk, childhood Hodgkin lymphoma.

NCI-GLOSS Definition: An abbreviation for a chemotherapy combination used with radiation therapy to treat low-risk childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, and etoposide.

Label: ABVE Regimen

NCI Thesaurus Code: C67162 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1879497  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
ABVE Regimen
ABVE regimen
Adriamycin-Bleomycin Sulfate-Vincristine Sulfate-Etoposide Regimen
DBVE regimen
DBVE Regimen

External Source Codes: 
PDQ Closed Trial Search ID 657148
PDQ Open Trial Search ID 657148 (check for NCI PDQ open clinical trial info)
UMLS CUI C1879497

Other Properties:
     Name Value (qualifiers indented underneath)
code C67162
DesignNote Source: PDQ
Legacy_Concept_Name ABVE_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom